vial of semaglutide Semaglutide: The benefits and risks the weight-loss wonder drug sweeping America Insurance for Semaglutide: Brand &

SGT-212SGT-212 / Gene Therapy / NeuromuscularFriedreich's ataxia (FA)Phase 1/2ActiveGlobal SGT-501SGT-501 / Gene Therapy / CardiacRYR2-Mediated CPVTPhase 1/2ActiveGlobalCASQ2-Mediated CPVTPreclinicalActiveGlobal SGT-601SGT-601 / TNNT2 / Gene Therapy / CardiacTNNT2-Mediated Dilated Cardiomyopathy (DCM)PreclinicalActiveGlobal SGT-401SGT-401 / BAG3 / Gene Therapy / CardiacBAG3-Mediated Dilated Cardiomyopathy (DCM)PreclinicalActiveGlobal SGT-701SGT-701 / RBM20 / Gene Therapy / CardiacRBM20-Mediated Dilated Cardiomyopathy (DCM)PreclinicalActiveGlobal Undisclosed Cardiac TargetsGene Therapy / CardiacGenetic cardiomyopathies and channelopathiesDiscoveryActiveGlobal 7assets SPY001SPY001 / 47 / Monoclonal antibody / GastroenterologyInflammatory Bowel Disease (IBD)Ulcerative Colitis SPY002SPY002 / TL1A / Monoclonal antibody / Gastroenterology / RheumatologyInflammatory Bowel Disease (IBD)Rheumatoid Arthritis (RA) SPY003SPY003 / IL-23 / Monoclonal antibody / GastroenterologyInflammatory Bowel Disease (IBD) SPY120SPY120 / 47 + TL1A / Combination / GastroenterologyInflammatory Bowel Disease (IBD) SPY130SPY130 / 47 + IL-23 / Combination / GastroenterologyInflammatory Bowel Disease (IBD) SPY230SPY230 / TL1A + IL-23 / Combination / GastroenterologyInflammatory Bowel Disease (IBD)Ulcerative Colitis SPY072SPY072 / TL1A / Monoclonal antibody / RheumatologyRheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (axSpA) 7assets 7assets 7assets VY7523VY-TAU01 / Tau / Monoclonal Antibody / NeurologyAlzheimer's DiseasePhase 1OngoingUnited States VY1706Tau / AAV Gene Therapy / NeurologyAlzheimer's DiseaseIND-EnablingOngoingUnited States APOE Gene TherapyAPOE / AAV Gene Therapy / NeurologyAlzheimer's DiseasePreclinicalOngoing NBIB-'223NBIB-223 / Frataxin (FXN) / AAV Gene Therapy / NeurologyFriedreich's Ataxia (FA)IND-EnablingOngoing GBA1 Gene TherapyGBA1 / AAV Gene Therapy / NeurologyParkinson's Disease and GBA1-mediated diseasesIND-EnablingOngoing Novartis Partnered ProgramsUndisclosed / AAV Gene Therapy / NeurologyHuntington's Disease, Spinal Muscular Atrophy (SMA), UndisclosedPreclinicalOngoing Alexion Partnered ProgramUndisclosed / AAV Gene Therapy / NeurologyUndisclosed Neurological DiseasePreclinicalOngoing 6assets RemlifanserinACP-204 / 5-HT2A receptor / inverse agonist / Neurological DisordersAlzheimers Disease PsychosisPhase 2RecruitingLewy Body Dementia with PsychosisPhase 2 ACP-211ACP-211 / selectively deuterated R-norketamine / Neurological DisordersMajor Depressive DisorderPhase 2 ACP-711ACP-711 / GABAA 3 / modulator / Neurological DisordersEssential TremorPhase 1 ACP-271ACP-271 / GPR88 / agonist / Neurological Disorders

Mir Vinyals (University of Zurich) for providing us with purified roGFP1-iE protein

One of the bigger concerns, to us as pharmacists, is the loss of bone density

Jafari, A., Noormohammadi, Z., Askari, M